HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members
Why a doctor should
Username/Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Poor sleep in women with postnatal depression linked to depression
Postpartum women with insomnia may be more likely to suffer from depression,...
Published Thursday 02 July 2009

Researchers could develop kidney disease treatment following discovery
A new discovery could lead to the improved diagnosis and treatment of...
Published Thursday 02 July 2009

Peptide nanoparticles could offer improved meningitis treatment
Doctors could soon be able to treat bacterial meningitis more effectively thanks...
Published Wednesday 01 July 2009

Treatment combination could benefit hepatitis C patients
Hepatitis C patients could benefit from a new combination of treatments, researchers...
Published Tuesday 30 June 2009

Insomnia is particularly severe among war veterans
War veterans suffering from insomnia and post-deployment adjustment disorders have symptoms as...
Published Tuesday 30 June 2009

Research could pave the way for new arthritis treatments
A new treatment for rheumatoid arthritis could be developed following a discovery...
Published Monday 29 June 2009

Teenagers are using less contraception, study suggests
The progress made in terms of contraceptive use among teenagers has stalled,...
Published Friday 26 June 2009

Enzyme helps to destroy mutated protein associated with Parkinson's
A naturally-occurring enzyme in the brain has been discovered which helps to...
Published Friday 26 June 2009

People who are civically engaged may be less likely to suffer from asthma
Areas with restaurants, cultural hubs and entertainment facilities may have lower rates...
Published Thursday 25 June 2009

Omacetaxine offers hope to CML patients
A new drug being developed by ChemGenex Pharmaceuticals could offer hope to...
Published Wednesday 24 June 2009

More Medical News
The term “isolated systolic hypertension” (ISH) describes raised systolic blood pressure with normal or low diastolic blood pressure. Some guidelines recognise two grades of isolated systolic hypertension: Lysosomal storage disorders (LSDs) are a group of progressive and often fatal genetic diseases that are caused by an inborn error of metabolism Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. The NSCLCs account for 80% of all lung cancers and can be further subdivided into squamous-cell carcinoma, large-cell carcinoma and adenocarcinoma (which includes bronchioloalveolar-cell carcinoma [BAC]
EPG Terms of Use

© 2001-2008 Copyright IMR International Ltd

All rights are reserved. The information held within the EPG System is issued by IMR International for closed distribution. The information presented is protected under the Berne Convention for the Protection of Literature and Artistic works, under other international conventions and under national laws on copyright and neighbouring rights.

In view of the possibility of human error by the authors, editors, or publishers of the material contained herein, neither IMR International or EMA (the European Medical Association) or any other party involved in the preparation of this material warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such. Medical professionals should confirm the information contained herein with other sources.

External links/websites and affiliates - EPG Online, IMR International, the European Medical Association, our sponsors, advertisers and partners do not accept responsibility for content held within external websites linking to or from epgonline.org europeanprescriberguide.com or imrmedia.net. The content of any such website in no way represents the opinions of the EPG/IMR/EMA. Such links are supplied purely as 'suggested links', the content of which is in no way waranteed for accuracy or independence.

Non-professionals reading patient articles herein should review the information carefully with their professional health care provider. The information is not intended to replace medical advice offered by physicians.

IMR International and other parties involved herein make no representations or warranties with respect to any treatment, action, or application of medication or preparation by any person following the information offered or provided within or through the EPG or any other party involved herein.

Neither IMR International Limited or any other party involved herein will be liable for any direct, indirect, consequential, special, exemplary or other damages arising there from.

Your use of this Website and the data/information held therin constitutes your acceptance of these terms and conditions.

It is also strictly forbidden to use the EPG or the European Medical Association (EMA) logo's and or other EPG related graphics without authorisation in writing. When permission has been granted, the EPG Logo has to be hyperlinked to the EPG Online website home page. Applications and inquiries should be addressed to contact@epgonline.org.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by either IMR International or EMA.

IMR International does not warrant that the information held within the EPG is complete and correct. In no event shall IMR International, the EPG or their partners/subcontractors be liable for any direct, indirect, special or consequential damages caused by any failure of performance, mistakes, omissions, interruptions, deletion of files, defects, delays in operations or transmission, communications lines failure, theft, destruction, unauthorised access to or use of the EPG Online, EPG Specialist, EPG Educational Content Library or EPG Software records, files or programmes, or for any failure or inability to perform by IMR International, EPG or its subcontractors due to any cause beyond their control.

By registering as a, EPG user/member (EPG Online, Software or WAP), you are confirming your status as a medical doctor, physician, clinical specialist or otherwise healthcare professional, the service is designed for professional use and the EPG, it's publishers IMR International Limited, sponsors or suppliers can in no way be held responsible or liable for any harm, damage either financially or physically, death or otherwise as a result of any professional or non-professional accessing the information published herein. Professionals are cautioned to always research information related to prescribing or treatment from more than one recognised source and are solely responsibile for any decision taken regarding treatment of a patient based upon the material herein.

Furthermore, by registering as an EPG user/member, the user/member confirms that they understand that content contained within the EPG System is made available for a European audience. For country-specific data please consult local Health Authorities or Medicines Agencies, as Product Information, treatment guidelines, and other clinical data may vary from one country to another.

By registering as an EPG user/member you accept that you may occasionally receive promotional and non-promotional correspondance from us.

Extracts of the information from the website may be reviewed, reproduced or translated for research or private study but not for sale or for use in conjunction with commercial purposes. Any use of information from the website should be accompanied by an acknowledgement of IMR International or the EPG Online as the source, citing the uniform resource locator (URL) of the site www.imrmedia.net or www.epgonline.org. Reproduction or translation of substantial portions of the website/system/CD ROM, or any use other than for educational or other non-commercial purposes, require explicit, prior authorisation in writing.

How we use your personal data (summary)

Please visit our privacy policy for more information on how we use/store your personal data

By registering as an EPG User you agree that your personal data may be used by IMR International for the purposes of periodic contact (where you have consented during registration) or for the purposes of market research. You also agree that IMR International may retrieve anonymous information regarding your activity on this and other IMR International web-sites - where you have used your EPG username and password for access - for the purpose of creating a user & activity profile, including your profession, licence number and other pertinent information. This information is held securely and not shared with any 3rd party. From time to time we may provide anonymous access to our database to 3rd party organisations for the purposes of market research, clinical trials, studies or marketing activity. Your personal information will not be passed to these organisations unless you expressly agree seperately over and above these terms & conditions of use.

IMR International reserves the right to add, modify, or delete any of the services offered on its website at any time.

TREATMENT IN FOCUS

Cystic Fibrosis

DRUG UPDATES Drug updates feed

CONNECT

EMAIL BULLETINS

DISEASE CENTRES Disease Centres feed

MEDICAL NEWS EPG News Feed

RESEARCH

GOOGLE SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed


Copyright © 1999 - 2009 EPG ONLINE